Loading…

Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway

Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to preve...

Full description

Saved in:
Bibliographic Details
Published in:Drug design, development and therapy development and therapy, 2023-11, Vol.17, p.3363-3383
Main Authors: Jin, Xiaoming, He, Riming, Lin, Yunxin, Liu, Jiahui, Wang, Yuzhi, Li, Zhongtang, Liao, Yijiao, Yang, Shudong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3
container_end_page 3383
container_issue
container_start_page 3363
container_title Drug design, development and therapy
container_volume 17
creator Jin, Xiaoming
He, Riming
Lin, Yunxin
Liu, Jiahui
Wang, Yuzhi
Li, Zhongtang
Liao, Yijiao
Yang, Shudong
description Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p
doi_str_mv 10.2147/DDDT.S433994
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_77bd4e3e976f46999ddcd2b0de827321</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A778571124</galeid><doaj_id>oai_doaj_org_article_77bd4e3e976f46999ddcd2b0de827321</doaj_id><sourcerecordid>A778571124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3</originalsourceid><addsrcrecordid>eNptkkGL2zAQhU1podttb_0BhkLpoUkkWbasY0i62dCULmQLvYmxNIoVHCsryZT8-zqbpexCmcMMj-89GHhZ9pGSKaNczJbL5f10y4tCSv4qu6JUiEld1_T1s_tt9i7GPSFVUTFylT1sW-xjO4CzQ74K0A8d5vOUsB8gYcznekiYf3emx1O-7vdDOOXN-Wpd45Lrd_kNhuCPyUcX8x9o3GgzZ-RYFrPtZiHmlM5Wd795fgep_QOn99kbC13ED0_7Ovt18-1-cTvZ_FytF_PNRHMm0kSXhHFqqGR1RRsEKq0Fo4nlwKCwoGVZldCYklDC0FpJCeUABakoI9Y2xXW2vuQaD3t1DO4A4aQ8OPUo-LBTEJLTHSohGsOxQCkqyysppTHasIYYrJkoGB2zvlyyjsE_DBiTOrioseugRz9ExWpZCiJKwUb00wXdwZjseutTAH3G1VyIuhSUMj5S0_9Q4xg8OO17tG7UXxg-PzO0CF1qo--G5HwfX4JfL6AOPsaA9t_rlKhzS9S5JeqpJcVfcVGsmw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2895707572</pqid></control><display><type>article</type><title>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jin, Xiaoming ; He, Riming ; Lin, Yunxin ; Liu, Jiahui ; Wang, Yuzhi ; Li, Zhongtang ; Liao, Yijiao ; Yang, Shudong</creator><creatorcontrib>Jin, Xiaoming ; He, Riming ; Lin, Yunxin ; Liu, Jiahui ; Wang, Yuzhi ; Li, Zhongtang ; Liao, Yijiao ; Yang, Shudong</creatorcontrib><description><![CDATA[Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p<0.01) and BUN (p<0.0001) levels, pathological damage (p<0.0001), dead cells in the tubular epithelium (p<0.0001) and iron deposition (p<0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p<0.01), the expressions of high mobility group box 1 (UMGB1, p<0.05) and interleukin (IL)-17 (p<0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p<0.01), and catalase (CAT, p<0.05), and alleviated mitochondrial dysfunction (p<0.05). More importantly, SSF regulated iron transport and intracellular iron overload and reduced the expression of ferritin (p<0.05). Moreover, it downregulated the expressions of cyclo-oxygenase-2 (Cox-2, p<0.001), acid CoA ligase 4 (ACSL4, p<0.05), and solute carrier family 7, member 11 (SLC7A11, p<001), upregulated glutathione peroxidase 4 (GPX4, p<0.01) and p53 (p<0.01), and decreased 4-hydroxynonenal (4-HNE) level (p<0.001). Conclusion: SSF attenuates AKI by inhibiting ferroptosis mediated by p53/SLC7A11/GPX4 pathway. Keywords: acute kidney injury, cisplatin, ferroptosis, shenshuaifu granule, p53/SLC7A11/GPX4 pathway]]></description><identifier>ISSN: 1177-8881</identifier><identifier>EISSN: 1177-8881</identifier><identifier>DOI: 10.2147/DDDT.S433994</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>acute kidney injury ; Cell death ; cisplatin ; Ferritin ; ferroptosis ; High performance liquid chromatography ; Inflammation ; p53/slc7a11/gpx4 pathway ; shenshuaifu granule ; Superoxide ; Tumor proteins ; Urea</subject><ispartof>Drug design, development and therapy, 2023-11, Vol.17, p.3363-3383</ispartof><rights>COPYRIGHT 2023 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924,37012</link.rule.ids></links><search><creatorcontrib>Jin, Xiaoming</creatorcontrib><creatorcontrib>He, Riming</creatorcontrib><creatorcontrib>Lin, Yunxin</creatorcontrib><creatorcontrib>Liu, Jiahui</creatorcontrib><creatorcontrib>Wang, Yuzhi</creatorcontrib><creatorcontrib>Li, Zhongtang</creatorcontrib><creatorcontrib>Liao, Yijiao</creatorcontrib><creatorcontrib>Yang, Shudong</creatorcontrib><title>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</title><title>Drug design, development and therapy</title><description><![CDATA[Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p<0.01) and BUN (p<0.0001) levels, pathological damage (p<0.0001), dead cells in the tubular epithelium (p<0.0001) and iron deposition (p<0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p<0.01), the expressions of high mobility group box 1 (UMGB1, p<0.05) and interleukin (IL)-17 (p<0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p<0.01), and catalase (CAT, p<0.05), and alleviated mitochondrial dysfunction (p<0.05). More importantly, SSF regulated iron transport and intracellular iron overload and reduced the expression of ferritin (p<0.05). Moreover, it downregulated the expressions of cyclo-oxygenase-2 (Cox-2, p<0.001), acid CoA ligase 4 (ACSL4, p<0.05), and solute carrier family 7, member 11 (SLC7A11, p<001), upregulated glutathione peroxidase 4 (GPX4, p<0.01) and p53 (p<0.01), and decreased 4-hydroxynonenal (4-HNE) level (p<0.001). Conclusion: SSF attenuates AKI by inhibiting ferroptosis mediated by p53/SLC7A11/GPX4 pathway. Keywords: acute kidney injury, cisplatin, ferroptosis, shenshuaifu granule, p53/SLC7A11/GPX4 pathway]]></description><subject>acute kidney injury</subject><subject>Cell death</subject><subject>cisplatin</subject><subject>Ferritin</subject><subject>ferroptosis</subject><subject>High performance liquid chromatography</subject><subject>Inflammation</subject><subject>p53/slc7a11/gpx4 pathway</subject><subject>shenshuaifu granule</subject><subject>Superoxide</subject><subject>Tumor proteins</subject><subject>Urea</subject><issn>1177-8881</issn><issn>1177-8881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkkGL2zAQhU1podttb_0BhkLpoUkkWbasY0i62dCULmQLvYmxNIoVHCsryZT8-zqbpexCmcMMj-89GHhZ9pGSKaNczJbL5f10y4tCSv4qu6JUiEld1_T1s_tt9i7GPSFVUTFylT1sW-xjO4CzQ74K0A8d5vOUsB8gYcznekiYf3emx1O-7vdDOOXN-Wpd45Lrd_kNhuCPyUcX8x9o3GgzZ-RYFrPtZiHmlM5Wd795fgep_QOn99kbC13ED0_7Ovt18-1-cTvZ_FytF_PNRHMm0kSXhHFqqGR1RRsEKq0Fo4nlwKCwoGVZldCYklDC0FpJCeUABakoI9Y2xXW2vuQaD3t1DO4A4aQ8OPUo-LBTEJLTHSohGsOxQCkqyysppTHasIYYrJkoGB2zvlyyjsE_DBiTOrioseugRz9ExWpZCiJKwUb00wXdwZjseutTAH3G1VyIuhSUMj5S0_9Q4xg8OO17tG7UXxg-PzO0CF1qo--G5HwfX4JfL6AOPsaA9t_rlKhzS9S5JeqpJcVfcVGsmw</recordid><startdate>20231130</startdate><enddate>20231130</enddate><creator>Jin, Xiaoming</creator><creator>He, Riming</creator><creator>Lin, Yunxin</creator><creator>Liu, Jiahui</creator><creator>Wang, Yuzhi</creator><creator>Li, Zhongtang</creator><creator>Liao, Yijiao</creator><creator>Yang, Shudong</creator><general>Dove Medical Press Limited</general><general>Dove Medical Press</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20231130</creationdate><title>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</title><author>Jin, Xiaoming ; He, Riming ; Lin, Yunxin ; Liu, Jiahui ; Wang, Yuzhi ; Li, Zhongtang ; Liao, Yijiao ; Yang, Shudong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>acute kidney injury</topic><topic>Cell death</topic><topic>cisplatin</topic><topic>Ferritin</topic><topic>ferroptosis</topic><topic>High performance liquid chromatography</topic><topic>Inflammation</topic><topic>p53/slc7a11/gpx4 pathway</topic><topic>shenshuaifu granule</topic><topic>Superoxide</topic><topic>Tumor proteins</topic><topic>Urea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jin, Xiaoming</creatorcontrib><creatorcontrib>He, Riming</creatorcontrib><creatorcontrib>Lin, Yunxin</creatorcontrib><creatorcontrib>Liu, Jiahui</creatorcontrib><creatorcontrib>Wang, Yuzhi</creatorcontrib><creatorcontrib>Li, Zhongtang</creatorcontrib><creatorcontrib>Liao, Yijiao</creatorcontrib><creatorcontrib>Yang, Shudong</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Drug design, development and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Xiaoming</au><au>He, Riming</au><au>Lin, Yunxin</au><au>Liu, Jiahui</au><au>Wang, Yuzhi</au><au>Li, Zhongtang</au><au>Liao, Yijiao</au><au>Yang, Shudong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway</atitle><jtitle>Drug design, development and therapy</jtitle><date>2023-11-30</date><risdate>2023</risdate><volume>17</volume><spage>3363</spage><epage>3383</epage><pages>3363-3383</pages><issn>1177-8881</issn><eissn>1177-8881</eissn><abstract><![CDATA[Background: Acute kidney injury (AKI) is a common clinical condition resulting in a rapid decline in renal function, and requires improvement in effective preventive measures. Ferroptosis, a novel form of cell death, is closely related to AKI. Shenshuaifu granule (SSF) has been demonstrated to prevent AKI through suppressing inflammation and apoptosis. Objective: This study aimed to explore whether SSF can inhibit ferroptosis in AKI. Methods: Active ingredients in SSF were detected through HPLC-MS/MS, and their binding abilities with ferroptosis were evaluated by molecular docking. Then, male C57/BL/6J mice were randomly divided into control, cisplatin, and cisplatin+SSF groups. In the latter two groups, mice were intraperitoneally injected with 20 mg/kg of cisplatin. For five consecutive days prior to cisplatin injection, mice in the cisplatin+SSF group were gavaged with 5.2 g/kg of SSF per day. 72 h after cisplatin injection, the mice were sacrificed. Serum creatinine (SCr) and blood urea nitrogen (BUN) were measured to evaluate renal function. H&E and FAS staining were used to observe pathological damage of kidney. Cell death was observed by TUNEL staining, and iron accumulation in kidneys of mice was detected by Prussian blue staining. Western blotting, immunohis-tochemistry, and immunofluorescence were used to investigate the presence of inflammation, oxidative stress, mitochondrial dysfunction, iron deposition, and lipid peroxidation in mouse kidneys. Results: Active ingredients in SSF had strong affinities with ferroptosis. SSF reduced SCr (p<0.01) and BUN (p<0.0001) levels, pathological damage (p<0.0001), dead cells in the tubular epithelium (p<0.0001) and iron deposition (p<0.01) in mice with cisplatin induced AKI. And SSF downregulated macrophage infiltration (p<0.01), the expressions of high mobility group box 1 (UMGB1, p<0.05) and interleukin (IL)-17 (p<0.05), upregulated superoxide dismutase (SOD) 1 and 2 (p<0.01), and catalase (CAT, p<0.05), and alleviated mitochondrial dysfunction (p<0.05). More importantly, SSF regulated iron transport and intracellular iron overload and reduced the expression of ferritin (p<0.05). Moreover, it downregulated the expressions of cyclo-oxygenase-2 (Cox-2, p<0.001), acid CoA ligase 4 (ACSL4, p<0.05), and solute carrier family 7, member 11 (SLC7A11, p<001), upregulated glutathione peroxidase 4 (GPX4, p<0.01) and p53 (p<0.01), and decreased 4-hydroxynonenal (4-HNE) level (p<0.001). Conclusion: SSF attenuates AKI by inhibiting ferroptosis mediated by p53/SLC7A11/GPX4 pathway. Keywords: acute kidney injury, cisplatin, ferroptosis, shenshuaifu granule, p53/SLC7A11/GPX4 pathway]]></abstract><pub>Dove Medical Press Limited</pub><doi>10.2147/DDDT.S433994</doi><tpages>21</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1177-8881
ispartof Drug design, development and therapy, 2023-11, Vol.17, p.3363-3383
issn 1177-8881
1177-8881
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_77bd4e3e976f46999ddcd2b0de827321
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central
subjects acute kidney injury
Cell death
cisplatin
Ferritin
ferroptosis
High performance liquid chromatography
Inflammation
p53/slc7a11/gpx4 pathway
shenshuaifu granule
Superoxide
Tumor proteins
Urea
title Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T00%3A53%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Shenshuaifu%20Granule%20Attenuates%20Acute%20Kidney%20Injury%20by%20Inhibiting%20Ferroptosis%20Mediated%20by%20p53/SLC7A11/GPX4%20Pathway&rft.jtitle=Drug%20design,%20development%20and%20therapy&rft.au=Jin,%20Xiaoming&rft.date=2023-11-30&rft.volume=17&rft.spage=3363&rft.epage=3383&rft.pages=3363-3383&rft.issn=1177-8881&rft.eissn=1177-8881&rft_id=info:doi/10.2147/DDDT.S433994&rft_dat=%3Cgale_doaj_%3EA778571124%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-c50241d192861bea19ffadc0f4a2a3fac9565abd50102eff91014aa306120ffb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2895707572&rft_id=info:pmid/&rft_galeid=A778571124&rfr_iscdi=true